Kinetic study on the reaction of cisplatin with metallothionein

Drug Metabolism and Disposition

Volumn 31, Issue 7, 2003, Pages 916-923

  Hagrman, Douglas ^a   Goodisman, Jerry ^b   Dabrowiak, James C ^b   Souid, Abdul Kader ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b SYRACUSE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; CISPLATIN; METALLOTHIONEIN; ZINC;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSOL; DRUG PROTEIN BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; KINETICS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; REACTION TIME; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; CADMIUM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CISPLATIN; CYTOSOL; DRUG RESISTANCE; ERGOTHIONEINE; HUMANS; KINETICS; LEUKOCYTES; METALLOTHIONEIN; PLATINUM; PROTEIN BINDING; RATS; SPECTROPHOTOMETRY, ATOMIC; SPECTROPHOTOMETRY, ULTRAVIOLET; ZINC;

EID: 0038311989     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.7.916     Document Type: Article

References (34)

1. 1H) DEPT NMR. J Inorg Biochem 38:305-326.
2. 1H} DEPT NMR. J Inorg Biochem 38:327-345.
3. Bose RN, Ghosh SK, and Moghaddas S (1997) Kinetic analysis of the cis-diamminedichloro-platinum (II)-cysteine reaction: implications to the extent of platinum-DNA binding. J Inorg Biochem 65:199-205.
4. Corden BJ, Fine RL, Ozols RF, and Collins JM (1985) Clinical pharmacology of high-dose cisplatin, Cancer Chemother Pharmacol 14:38-41.
5. Dabrowiak JC, Goodisman J, and Souid A-K (2002) Kinetic study of the reaction of cisplatin with thiols. Drug Metab Dispos 30:1378-1384.
6. Dedon PC and Borch RF (1987) Characterization of the reactions of platinum antitumor agents with biologic and non-biologic sulfur-containing nucleophiles. Biochem Pharmacol 36:1955-1964.
7. Demarcq C, Bunch RT, Creswell D, and Eastman A (1994) The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells. Cell Growth Differ 5:983-993.
8. Eastman A (1991) Mechanisms of resistance to cisplatin, in Molecular and Clinical Advances in Anticancer Drug Resistance (Ozols RF ed) pp 233-249, Kluwer Academic Publishers, Norwell, MA.
9. 2+ and Co2+. J Inorg Biochem 88:144-152.
10. Gelasco A and Lippard SJ (1999) Anticancer activity of cisplatin and related compounds. Top Biol Inorg Chem 1: 1-43.
11. Godwin A, Meister A, O'Dwyer P, Huang C, Hamilton M, and Anderson M (1992) High resistance to cisplatin in human ovarian cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89:3070-3074.
12. Kagi JHR and Vallee BL (1960) Metallothionein, a cadmium and zinc containing protein from equine renal cortex. J Biol Chem 236:3460-3465.
13. Kagi JHR, Vasak M, Lerch K, Glig DEO, Hunziker P, Bernhard WR, and Good M (1984) Structure of mammalian metallothionein. Environ Health Perspect 54:93-103.
14. Kraker A, Schmidt J, Krezoski S, and Petering DH (1985) Binding of cis-dichlorodiammine platinum (II) to metallothionoine in Ehrlich cells. Biochem Biophys Res Commun 31:786-792.
15. Li T, Kraker AJ, Shaw CF, and Petering DH (1980) Ligand substitution reactions of metallo-thioneins with EDTA and apo-carbonic anhydrase. Proc Natl Acad Sci USA 77:6334-6338.
16. Meijer C, Timmer A, De Vries EGE, Groten JP, Knol A, Zwart N, Dam WA, Sleijfer DT, and Mulder NH (2000) Role of metallothionein in cisplatin sensitivity in germ-cell tumors. Int J Cancer 85:777-781.
17. Mistry P, Kelland LR, Able S, and Harrap KR (1991) The relationship between glutathione, glutathione-s-transferase and cytotoxicity of platinum drugs and melphalan in 8 human ovarian-carcinoma cell-lines. Br J Cancer 64:215-220.
18. Pattanaik A, Bachowski G, Laib J, Lemkuil D, Shaw F III, Petering DH, Hitchcock A, and Saryan L (1992) Properties of the reaction of cis-dichlorodiammineplatinum (II) with metal-lothionein. J Biol Chem 267:16121-16128.
19. Perez-Benito JF, Arias C, and Amat E (1995) A kinetic study of the reactions of cisplatin with biological thiols. New J Chem 19:1098-1094.
20. Reedijk J and Teuben JM (1999) Platinum-sulfur interactions involved in antitumor drugs, rescue agents and biomolecules, in Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug (Lippert B ed) pp 339-362, WILEY-VCH Verlag GmbH, Weinheim, Germany.
21. Richon VM, Schulte N, and Eastman A (1987) High resistance to cis- diamminedichloroplatinum (II) in murine leukemia-Ll210 cells. Cancer Res 47:2056-2061.
22. Sadowitz PD, Hubbard BA, Dabrowiak JC, Goodisman J, Tacka KA, Aktas MK, Cunningham MJ, Dubowy RL, and Souid A-K (2002) Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs. Drug Metab Dispos 30:183-190.
23. Satoh M, Kloth DM, Kadhim SA, Chin JL, Naganuma A, Imura N, and Cherian MG (1993) Modulation of both cisplatin and drug resistance in murine bladder tumor by controlling metallothionein synthesis. Cancer Res 53:1829-1832.
24. Schilder R, Hall L, Monks A, Handel L, Forance A, Ozols R, Fojo A, and Hamilton T (1990) Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. Int J Cancer 45:416-422.
25. Souid A-K, Dubowy RL, Blaney SM, Hershon L, Sullivan J, McLeod WD, and Bernstein ML (2003) Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors: Children's Oncology Group Trial 9970. Clin Cancer Res 9:703-710
26. Souid A-K, Fahey RC, Aktas MK, Sayin OA, Karjoo S, Newton GL, Sadowitz PD, Dubowy RL, and Bernstein ML (2001) Blood thiols following amifostine and mesna infusions, a pediatric oncology group study. Drug Metab Dispos 29:1-7.
27. Souid A-K, Fahey RC, Dubowy RL, Newton GL, and Bernstein ML (1999) WR-2721 (amifos-tine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a pediatric oncology group study. Cancer Chemother Pharmacol 44:498-504.
28. Souid A-K, Newton GL, Dubowy RL, Fahey RC, and Bernstein ML (1998) Determination of the chemoprotective agent WR-2721 (amifostine, Ethyol) and metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography. Cancer Chemother Pharmacol 42:400-406.
29. Tacka KA, Dabrowiak JC, Goodisman J, and Souid A-K (2002) Kinetic analysis of the reactions of 4-hydroperoxycyclophosphamide and acrolein with glutathione, mesna and WR-1065. Drug Metab Dispos 30:875-882.
30. Vasak M (1991) Large-scale preparation of metallothionein: biological sources. Methods Enzy-mol 205:39-41.
31. Volckova E, Dudones LP, and Bose RN (2002) HPLC determination of binding of cisplatin to DNA in the presence of biological thiols: implications of dominant platinum-thiol binding to its anticancer action. Pharm Res (NY) 19:124-131.
32. Ye B, Maret W, and Vallee BL (2000) Zinc metallothionein imported into liver mitochondria modulates respiration. Proc Natl Acad Sci USA 98:2317-2322.
33. Zhang B and Tang W (1994) Kinetics of the reaction of platinum(II) complexes with metallo-thionein. J Inorg Biochem 56:143-153.
34. Zwelling LA, Anderson T, and Kohn KW (1979) DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum (II) diamminedichloride in L 1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res 39:365-369.